text:
Coronary artery disease
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Coronary artery disease
Synonyms
Atherosclerotic heart disease,[1] atherosclerotic vascular disease,[2] coronary heart disease[3]
Illustration depicting atherosclerosis in a coronary artery.
Specialty
Cardiology, cardiac surgery
Symptoms
Chest pain, shortness of breath[4]
Complications
Heart failure, abnormal heart rhythms[5]
Causes
Atherosclerosis of the arteries of the heart[6]
Risk factors
High blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol[6][7]
Diagnostic method
Electrocardiogram, cardiac stress test, coronary computed tomographic angiography, coronary angiogram[8]
Prevention
Healthy diet, regular exercise, maintaining a healthy weight, not smoking[9]
Treatment
Percutaneous coronary intervention (PCI), coronary artery bypass surgery (CABG)[10]
Medication
Aspirin, beta blockers, nitroglycerin, statins[10]
Frequency
110 million (2015)[11]
Deaths
8.9 million (2015)[12]
Coronary artery disease (CAD), also known as ischemic heart disease (IHD),[13] refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death.[14] It is within the group of cardiovascular diseases of which it is the most common type.[15] A common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw.[4] Occasionally it may feel like heartburn. Usually symptoms occur with exercise or emotional stress, last less than a few minutes, and improve with rest.[4] Shortness of breath may also occur and sometimes no symptoms are present.[4] Occasionally, the first sign is a heart attack.[5] Other complications include heart failure or an abnormal heartbeat.[5]
Risk factors include high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, depression, and excessive alcohol.[6][7][16] The underlying mechanism involves reduction of blood flow and oxygen to the heart muscle due to atherosclerosis of the arteries of the heart.[6] A number of tests may help with diagnoses including: electrocardiogram, cardiac stress testing, coronary computed tomographic angiography, and coronary angiogram, among others.[8]
Ways to reduce CAD risk include eating a healthy diet, regularly exercising, maintaining a healthy weight, and not smoking.[9] Medications for diabetes, high cholesterol, or high blood pressure are sometimes used.[9] There is limited evidence for screening people who are at low risk and do not have symptoms.[17] Treatment involves the same measures as prevention.[10][18] Additional medications such as antiplatelets (including aspirin), beta blockers, or nitroglycerin may be recommended.[10] Procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG) may be used in severe disease.[10][19] In those with stable CAD it is unclear if PCI or CABG in addition to the other treatments improves life expectancy or decreases heart attack risk.[20]
In 2015 CAD affected 110 million people and resulted in 8.9 million deaths.[11][12] It makes up 15.9% of all deaths making it the most common cause of death globally.[12] The risk of death from CAD for a given age has decreased between 1980 and 2010, especially in developed countries.[21] The number of cases of CAD for a given age has also decreased between 1990 and 2010.[22] In the United States in 2010 about 20% of those over 65 had CAD, while it was present in 7% of those 45 to 64, and 1.3% of those 18 to 45.[23] Rates are higher among men than women of a given age.[23]
Contents
[hide]
1 Signs and symptoms
2 Risk factors
2.1 Blood fats
2.2 Genetics
2.3 Other
3 Pathophysiology
4 Diagnosis
4.1 Stable angina
4.2 Acute coronary syndrome
4.3 Risk assessment
5 Prevention
5.1 Diet
5.2 Secondary prevention
6 Treatment
6.1 Medications
6.1.1 Aspirin
6.1.2 Anti-platelet therapy
6.2 Surgery
7 Epidemiology
8 Society and culture
8.1 Names
8.2 Support groups
8.3 Industry influence on research
9 Research
10 References
11 External links
Signs and symptoms[edit]
Chest pain that occurs regularly with activity, after eating, or at other predictable times is termed stable angina and is associated with narrowings of the arteries of the heart.
Angina that changes in intensity, character or frequency is termed unstable. Unstable angina may precede myocardial infarction. In adults who go to the emergency department with an unclear cause of pain, about 30% have pain due to coronary artery disease.[24]
Risk factors[edit]
Coronary artery disease has a number of well determined risk factors. These include high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, depression, family history, and excessive alcohol.[6][7][16] About half of cases are linked to genetics.[25] Smoking and obesity are associated with about 36% and 20% of cases, respectively.[26] Smoking just one cigarette per day about doubles the risk of CAD.[27] Lack of exercise has been linked to 7–12% of cases.[26][28] Exposure to the herbicide Agent Orange may increase risk.[29] Both rheumatoid arthritis and systemic lupus erythematosus are independent risk factors as well.[30][31]
Job stress appears to play a minor role accounting for about 3% of cases.[26] In one study, women who were free of stress from work life saw an increase in the diameter of their blood vessels, leading to decreased progression of atherosclerosis.[32] In contrast, women who had high levels of work-related stress experienced a decrease in the diameter of their blood vessels and significantly increased disease progression.[32] Having a type A behavior pattern, a group of personality characteristics including time urgency, competitiveness, hostility, and impatience,[33] is linked to an increased risk of coronary disease.[34]
Blood fats[edit]
High blood cholesterol (specifically, serum LDL concentrations). HDL (high density lipoprotein) has a protective effect over development of coronary artery disease.[35]
High blood triglycerides may play a role.[36]
High levels of lipoprotein(a),[37][38][39] a compound formed when LDL cholesterol combines with a protein known as apolipoprotein(a).
Dietary cholesterol does not appear to have a significant effect on blood cholesterol and thus recommendations about its consumption may not be needed.[40] Saturated fat is still a concern.[40]
Genetics[edit]
The heritability of coronary artery disease has been estimated between 40% and 60%.[41] Genome-wide association studies have identified around 60 genetic susceptibility loci for coronary artery disease.[42]
Other[edit]
Endometriosis in women under the age of 40.[43]
Depression and hostility appear to be risks.[44]
The number of categories of adverse childhood experiences (psychological, physical, or sexual abuse; violence against mother; or living with household members who were substance abusers, mentally ill, suicidal, or incarcerated) showed a graded correlation with the presence of adult diseases including coronary artery (ischemic heart) disease.[45]
Hemostatic factors: High levels of fibrinogen and coagulation factor VII are associated with an increased risk of CAD.[46]
Low hemoglobin.[47]
In the Asian population, the b fibrinogen gene G-455A polymorphism was associated with the risk of CHD.[48]
Pathophysiology[edit]
Micrograph of a coronary artery with the most common form of coronary artery disease (atherosclerosis) and marked luminal narrowing. Masson's trichrome.
Illustration depicting coronary artery disease
Limitation of blood flow to the heart causes ischemia (cell starvation secondary to a lack of oxygen) of the heart's muscle cells. The heart's muscle cells may die from lack of oxygen and this is called a myocardial infarction (commonly referred to as a heart attack). It leads to damage, death, and eventual scarring of the heart muscle without regrowth of heart muscle cells. Chronic high-grade narrowing of the coronary arteries can induce transient ischemia which leads to the induction of a ventricular arrhythmia, which may terminate into a dangerous heart rhythm known as ventricular fibrillation, which often leads to death.[49]
Typically, coronary artery disease occurs when part of the smooth, elastic lining inside a coronary artery (the arteries that supply blood to the heart muscle) develops atherosclerosis. With atherosclerosis, the artery's lining becomes hardened, stiffened, and accumulates deposits of calcium, fatty lipids, and abnormal inflammatory cells – to form a plaque. Calcium phosphate (hydroxyapatite) deposits in the muscular layer of the blood vessels appear to play a significant role in stiffening the arteries and inducing the early phase of coronary arteriosclerosis. This can be seen in a so-called metastatic mechanism of calciphylaxis as it occurs in chronic kidney disease and hemodialysis (Rainer Liedtke 2008). Although these people suffer from a kidney dysfunction, almost fifty percent of them die due to coronary artery disease. Plaques can be thought of as large "pimples" that protrude into the channel of an artery, causing a partial obstruction to blood flow. People with coronary artery disease might have just one or two plaques, or might have dozens distributed throughout their coronary arteries. A more severe form is chronic total occlusion (CTO) when a coronary artery is completely obstructed for more than 3 months.[50]
Cardiac syndrome X is chest pain (angina pectoris) and chest discomfort in people who do not show signs of blockages in the larger coronary arteries of their hearts when an angiogram (coronary angiogram) is being performed.[51] The exact cause of cardiac syndrome X is unknown. One explanation is microvascular dysfunction.[52] For reasons that are not well understood, women are more likely than men to have it; however, hormones and other risk factors unique to women may play a role.[53]
Diagnosis[edit]
Coronary angiogram of a man
Coronary angiogram of a woman
For symptomatic people, stress echocardiography can be used to make a diagnosis for obstructive coronary artery disease.[54] The use of echocardiography, stress cardiac imaging, and/or advanced non-invasive imaging is not recommended on individuals who are exhibiting no symptoms and are otherwise at low risk for developing coronary disease.[54][55]
The diagnosis of "Cardiac Syndrome X" – the rare coronary artery disease that is more common in women, as mentioned, is a diagnosis of exclusion. Therefore, usually the same tests are used as in any person with the suspected of having coronary artery disease:
Baseline electrocardiography (ECG)
Exercise ECG – Stress test
Exercise radioisotope test (nuclear stress test, myocardial scintigraphy)
Echocardiography (including stress echocardiography)
Coronary angiography
Intravascular ultrasound
Magnetic resonance imaging (MRI)
The diagnosis of coronary disease underlying particular symptoms depends largely on the nature of the symptoms. The first investigation is an electrocardiogram (ECG/EKG), both for "stable" angina and acute coronary syndrome. An X-ray of the chest and blood tests may be performed.[citation needed]
Stable angina[edit]
Main article: Angina pectoris
In "stable" angina, chest pain with typical features occurring at predictable levels of exertion, various forms of cardiac stress tests may be used to induce both symptoms and detect changes by way of electrocardiography (using an ECG), echocardiography (using ultrasound of the heart) or scintigraphy (using uptake of radionuclide by the heart muscle). If part of the heart seems to receive an insufficient blood supply, coronary angiography may be used to identify stenosis of the coronary arteries and suitability for angioplasty or bypass surgery.[56]
Stable coronary artery disease (SCAD) is also often called stable ischemic heart disease (SIHD).[57] A 2015 monograph explains that "Regardless of the nomenclature, stable angina is the chief manifestation of SIHD or SCAD."[57] There are U.S. and European clinical practice guidelines for SIHD/SCAD.[58][59]
Acute coronary syndrome[edit]
Main article: Acute coronary syndrome
This section does not cite any sources. Please help improve this section by adding citations to reliable sources. Unsourced material may be challenged and removed. (October 2015) (Learn how and when to remove this template message)
Diagnosis of acute coronary syndrome generally takes place in the emergency department, where ECGs may be performed sequentially to identify "evolving changes" (indicating ongoing damage to the heart muscle). Diagnosis is clear-cut if ECGs show elevation of the "ST segment", which in the context of severe typical chest pain is strongly indicative of an acute myocardial infarction (MI); this is termed a STEMI (ST-elevation MI) and is treated as an emergency with either urgent coronary angiography and percutaneous coronary intervention (angioplasty with or without stent insertion) or with thrombolysis ("clot buster" medication), whichever is available. In the absence of ST-segment elevation, heart damage is detected by cardiac markers (blood tests that identify heart muscle damage). If there is evidence of damage (infarction), the chest pain is attributed to a "non-ST elevation MI" (NSTEMI). If there is no evidence of damage, the term "unstable angina" is used. This process usually necessitates hospital admission and close observation on a coronary care unit for possible complications (such as cardiac arrhythmias – irregularities in the heart rate). Depending on the risk assessment, stress testing or angiography may be used to identify and treat coronary artery disease in patients who have had an NSTEMI or unstable angina.
Risk assessment[edit]
This section does not cite any sources. Please help improve this section by adding citations to reliable sources. Unsourced material may be challenged and removed. (October 2015) (Learn how and when to remove this template message)
There are various risk assessment systems for determining the risk of coronary artery disease, with various emphasis on different variables above. A notable example is Framingham Score, used in the Framingham Heart Study. It is mainly based on age, gender, diabetes, total cholesterol, HDL cholesterol, tobacco smoking and systolic blood pressure.
Prevention[edit]
Up to 90% of cardiovascular disease may be preventable if established risk factors are avoided.[60][61] Prevention involves adequate physical exercise, decreasing obesity, treating high blood pressure, eating a healthy diet, decreasing cholesterol levels, and stopping smoking. Medications and exercise are roughly equally effective.[62] High levels of physical activity reduce the risk of coronary artery disease by about 25%.[63]
Most guidelines recommend combining these preventive strategies. A 2015 Cochrane Review found some evidence that such an approach might help with blood pressure, body mass index, and waist circumference. However, there was insufficient evidence to show an effect on mortality or actual cardiovascular events.[64]
In diabetes mellitus, there is little evidence that very tight blood sugar control improves cardiac risk although improved sugar control appears to decrease other problems such as kidney failure and blindness. The World Health Organization (WHO) recommends "low to moderate alcohol intake" to reduce risk of coronary artery disease while high intake increases the risk.[65]
Diet[edit]
Main article: Diet and heart disease
A diet high in fruits and vegetables decreases the risk of cardiovascular disease and death.[66] Vegetarians have a lower risk of heart disease,[67][68] possibly due to their greater consumption of fruits and vegetables.[69] Evidence also suggests that the Mediterranean diet[70] and a high fiber diet lower the risk.[71]
The consumption of trans fat (commonly found in hydrogenated products such as margarine) has been shown to cause a precursor to atherosclerosis[72] and increase the risk of coronary artery disease.[73]
Evidence does not support a beneficial role for omega-3 fatty acid supplementation in preventing cardiovascular disease (including myocardial infarction and sudden cardiac death).[74][75] There is tentative evidence that intake of menaquinone (Vitamin K2), but not phylloquinone (Vitamin K1), may reduce the risk of CAD mortality.[76]
Secondary prevention[edit]
Secondary prevention is preventing further sequelae of already established disease. Lifestyle changes that have been shown to be effective to this goal include:
Weight control
Smoking cessation
Avoiding the consumption of trans fats (in partially hydrogenated oils)
Decrease psychosocial stress[77]
Exercise; aerobic exercise, like walking, jogging, or swimming, can reduce the risk of mortality from coronary artery disease.[78] Aerobic exercise can help decrease blood pressure and the amount of blood cholesterol (LDL) over time. It also increases HDL cholesterol which is considered as "good cholesterol".[79][80] Separate to the question of the benefits of exercise; it is unclear whether doctors should spend time counseling patients to exercise. The U.S. Preventive Services Task Force found "insufficient evidence" to recommend that doctors counsel patients on exercise but "it did not review the evidence for the effectiveness of physical activity to reduce chronic disease, morbidity and mortality", it only examined the effectiveness of the counseling itself.[81] The American Heart Association, based on a non-systematic review, recommends that doctors counsel patients on exercise.[82]
Treatment[edit]
There are a number of treatment options for coronary artery disease:[83]
Lifestyle changes
Medical treatment – drugs (e.g., cholesterol lowering medications, beta-blockers, nitroglycerin, calcium channel blockers, etc.);
Coronary interventions as angioplasty and coronary stent;
Coronary artery bypass grafting (CABG)
Medications[edit]
Statins, which reduce cholesterol, reduce the risk of coronary artery disease[84]
Nitroglycerin[85]
Calcium channel blockers and/or beta-blockers[86]
Antiplatelet drugs such as aspirin[86][87]
It is recommended that blood pressure typically be reduced to less than 140/90 mmHg.[88] The diastolic blood pressure however should not be lower than 60 mmHg.[vague] Beta blockers are recommended first line for this use.[88]
Aspirin[edit]
In those with no previous history of heart disease, aspirin decreases the risk of a myocardial infarction but does not change the overall risk of death.[89] It is thus only recommended in adults who are at increased risk for coronary artery disease[90] where increased risk is defined as "men older than 90 years of age, postmenopausal women, and younger persons with risk factors for coronary artery disease (for example, hypertension, diabetes, or smoking) are at increased risk for heart disease and may wish to consider aspirin therapy". More specifically, high-risk persons are "those with a 5-year risk ≥ 3%".[citation needed]
Anti-platelet therapy[edit]
Clopidogrel plus aspirin reduces cardiovascular events more than aspirin alone in those with a STEMI. In others at high risk but not having an acute event the evidence is weak.[91] Specifically, its use does not change the risk of death in this group.[92] In those who have had a stent more than 12 months of clopidogrel plus aspirin does not affect the risk of death.[93]
Surgery[edit]
Revascularization for acute coronary syndrome has a mortality benefit.[94] Percutaneous revascularization for stable ischaemic heart disease does not appear to have benefits over medical therapy alone.[95] In those with disease in more than one artery coronary artery bypass grafts appear better than percutaneous coronary interventions.[96][97] Newer "anaortic" or no-touch off-pump coronary artery revascularization techniques have shown reduced postoperative stroke rates comparable to percutaneous coronary intervention.[98]
Epidemiology[edit]
Deaths due to ischaemic heart disease per million persons in 2012
160–288
289–379
380–460
461–576
577–691
692–894
895–1,068
1,069–1,443
1,444–2,368
2,369-7233
Disability-adjusted life year for ischaemic heart disease per 100,000 inhabitants in 2004.[99]
no data
<350
350–700
700–1050
1050–1400
1400–1750
1750–2100
2100–2450
2450–2800
2800–3150
3150–3500
3500–4000
>4000
As of 2010, CAD was the leading cause of death globally resulting in over 7 million deaths.[100] This increased from 5.2 million deaths from CAD worldwide in 1990.[100] It may affect individuals at any age but becomes dramatically more common at progressively older ages, with approximately a tripling with each decade of life.[101] Males are affected more often than females.[101]
It is estimated that 60% of the world's cardiovascular disease burden will occur in the South Asian subcontinent despite only accounting for 20% of the world's population. This may be secondary to a combination of genetic predisposition and environmental factors. Organizations such as the Indian Heart Association are working with the World Heart Federation to raise awareness about this issue.[102]
Coronary artery disease is the leading cause of death for both men and women and accounts for approximately 600,000 deaths in the United States every year.[103] According to present trends in the United States, half of healthy 40-year-old men will develop CAD in the future, and one in three healthy 40-year-old women.[104] It is the most common reason for death of men and women over 20 years of age in the United States.[105]
Society and culture[edit]
Names[edit]
Other terms sometimes used for this condition are "hardening of the arteries" and "narrowing of the arteries".[106] In Latin it is known as morbus ischaemicus cordis (MIC).
Support groups[edit]
The Infarct Combat Project (ICP) is an international nonprofit organization founded in 1998 which tries to decrease ischemic heart diseases through education and research.[107][108]
Industry influence on research[edit]
In 2016 research into the archives of the[not in citation given]Sugar Association, the trade association for the sugar industry in the US, had sponsored an influential literature review published in 1965 in the New England Journal of Medicine that downplayed early findings about the role of a diet heavy in sugar in the development of CAD and emphasized the role of fat; that review influenced decades of research funding and guidance on healthy eating.[109][110][111][112][113]
Research[edit]
Further information: Atheroma and Atherosclerosis
Research efforts are focused on new angiogenic treatment modalities and various (adult) stem-cell therapies. A region on chromosome 17 was confined to families with multiple cases of myocardial infarction.[114] Other genome-wide studies have identified a firm risk variant on chromosome 9 (9p21.3).[115] However, these and other loci are found in intergenic segments and need further research in understanding how the phenotype is affected.[116]
A more controversial link is that between Chlamydophila pneumoniae infection and atherosclerosis.[117] While this intracellular organism has been demonstrated in atherosclerotic plaques, evidence is inconclusive as to whether it can be considered a causative factor.[118] Treatment with antibiotics in patients with proven atherosclerosis has not demonstrated a decreased risk of heart attacks or other coronary vascular diseases.[119]
Since the 1990s the search for new treatment options for coronary artery disease patients, particularly for so called "no-option" coronary patients, focused on usage of angiogenesis[120] and (adult) stem cell therapies. Numerous clinical trials were performed, either applying protein (angiogenic growth factor) therapies, such as FGF-1 or VEGF, or cell therapies using different kinds of adult stem cell populations. Research is still going on – with first promising results particularly for FGF-1[121][122] and utilization of endothelial progenitor cells.
Myeloperoxidase has been proposed as a biomarker.[123]
Dietary changes can decrease coronary artery disease. For example, data supports benefit from a plant-based diet and aggressive lipid lowering to improve heart disease.[124][needs update]
References[edit]
Jump up ^ "Coronary heart disease – causes, symptoms, prevention". Southern Cross Healthcare Group. Archived from the original on 3 March 2014. Retrieved 15 September 2013.
Jump up ^ Faxon, D. P. (1 June 2004). "Atherosclerotic Vascular Disease Conference: Executive Summary: Atherosclerotic Vascular Disease Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association". Circulation. 109 (21): 2595–2604. doi:10.1161/01.CIR.0000128517.52533.DB. PMID 15173041.
Jump up ^ "Coronary heart disease". NIH. Archived from the original on 12 September 2013. Retrieved 15 September 2013.
^ Jump up to: a b c d "What Are the Signs and Symptoms of Coronary Heart Disease?". 29 September 2014. Archived from the original on 24 February 2015. Retrieved 23 February 2015.
^ Jump up to: a b c "Coronary Artery Disease (CAD)". 12 March 2013. Archived from the original on 2 March 2015. Retrieved 23 February 2015.
^ Jump up to: a b c d e Mendis, Shanthi; Puska, Pekka; Norrving, Bo (2011). Global atlas on cardiovascular disease prevention and control (PDF) (1st ed.). Geneva: World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization. pp. 3–18. ISBN 9789241564373. Archived (PDF) from the original on 17 August 2014.
^ Jump up to: a b c Mehta, PK; Wei, J; Wenger, NK (16 October 2014). "Ischemic heart disease in women: A focus on risk factors". Trends in Cardiovascular Medicine. 25: 140–151. doi:10.1016/j.tcm.2014.10.005. PMC 4336825  . PMID 25453985.
^ Jump up to: a b "How Is Coronary Heart Disease Diagnosed?". 29 September 2014. Archived from the original on 24 February 2015. Retrieved 25 February 2015.
^ Jump up to: a b c "How Can Coronary Heart Disease Be Prevented or Delayed?". Archived from the original on 24 February 2015. Retrieved 25 February 2015.
^ Jump up to: a b c d e "How Is Coronary Heart Disease Treated?". 29 September 2014. Archived from the original on 24 February 2015. Retrieved 25 February 2015.
^ Jump up to: a b GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577  . PMID 27733282.
^ Jump up to: a b c GBD 2015 Mortality and Causes of Death, Collaborators. (8 October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903  . PMID 27733281.
Jump up ^ Bhatia, Sujata K. (2010). Biomaterials for clinical applications (Online-Ausg. ed.). New York: Springer. p. 23. ISBN 9781441969200. Archived from the original on 10 January 2017.
Jump up ^ Wong, ND (May 2014). "Epidemiological studies of CHD and the evolution of preventive cardiology". Nature Reviews. Cardiology. 11 (5): 276–89. doi:10.1038/nrcardio.2014.26. PMID 24663092.
Jump up ^ GBD 2013 Mortality and Causes of Death, Collaborators (17 December 2014). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385: 117–171. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604  . PMID 25530442.
^ Jump up to: a b Charlson, FJ; Moran, AE; Freedman, G; Norman, RE; Stapelberg, NJ; Baxter, AJ; Vos, T; Whiteford, HA (26 November 2013). "The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment". BMC Medicine. 11: 250. doi:10.1186/1741-7015-11-250. PMC 4222499  . PMID 24274053.
Jump up ^ Desai, CS; Blumenthal, RS; Greenland, P (April 2014). "Screening low-risk individuals for coronary artery disease". Current atherosclerosis reports. 16 (4): 402. doi:10.1007/s11883-014-0402-8. PMID 24522859.
Jump up ^ Boden, WE; Franklin, B; Berra, K; Haskell, WL; Calfas, KJ; Zimmerman, FH; Wenger, NK (October 2014). "Exercise as a therapeutic intervention in patients with stable ischemic heart disease: an underfilled prescription". The American Journal of Medicine. 127 (10): 905–11. doi:10.1016/j.amjmed.2014.05.007. PMID 24844736.
Jump up ^ Deb, S; Wijeysundera, HC; Ko, DT; Tsubota, H; Hill, S; Fremes, SE (20 November 2013). "Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review". JAMA. 310 (19): 2086–95. doi:10.1001/jama.2013.281718. PMID 24240936.
Jump up ^ Rezende, PC; Scudeler, TL; da Costa, LM; Hueb, W (16 February 2015). "Conservative strategy for treatment of stable coronary artery disease". World journal of clinical cases. 3 (2): 163–70. doi:10.12998/wjcc.v3.i2.163. PMC 4317610  . PMID 25685763.
Jump up ^ Moran, AE; Forouzanfar, MH; Roth, GA; Mensah, GA; Ezzati, M; Murray, CJ; Naghavi, M (8 April 2014). "Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study". Circulation. 129 (14): 1483–92. doi:10.1161/circulationaha.113.004042. PMC 4181359  . PMID 24573352.
Jump up ^ Moran, AE; Forouzanfar, MH; Roth, GA; Mensah, GA; Ezzati, M; Flaxman, A; Murray, CJ; Naghavi, M (8 April 2014). "The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study". Circulation. 129 (14): 1493–501. doi:10.1161/circulationaha.113.004046. PMC 4181601  . PMID 24573351.
^ Jump up to: a b Centers for Disease Control and Prevention, (CDC) (14 October 2011). "Prevalence of coronary heart disease—United States, 2006–2010". MMWR. Morbidity and Mortality Weekly Report. 60 (40): 1377–81. PMID 21993341.
Jump up ^ Kontos, MC; Diercks, DB; Kirk, JD (Mar 2010). "Emergency department and office-based evaluation of patients with chest pain". Mayo Clinic Proceedings. 85 (3): 284–99. doi:10.4065/mcp.2009.0560. PMC 2843115  . PMID 20194155.
Jump up ^ Dai, Xuming; et al. (2016). "Genetics of coronary artery disease and myocardial infarction". World Journal of Cardiology. National Center for Biotechnology Information, U.S. National Library of Medicine. 8 (1): 1–23. doi:10.4330/wjc.v8.i1.1. PMC 4728103  . PMID 26839654. CS1 maint: Explicit use of et al. (link)
^ Jump up to: a b c Kivimäki M, Nyberg ST, Batty GD, Fransson EI, Heikkilä K, Alfredsson L, Bjorner JB, Borritz M, Burr H, Casini A, Clays E, De Bacquer D, Dragano N, Ferrie JE, Geuskens GA, Goldberg M, Hamer M, Hooftman WE, Houtman IL, Joensuu M, Jokela M, Kittel F, Knutsson A, Koskenvuo M, Koskinen A, Kouvonen A, Kumari M, Madsen IE, Marmot MG, Nielsen ML, Nordin M, Oksanen T, Pentti J, Rugulies R, Salo P, Siegrist J, Singh-Manoux A, Suominen SB, Väänänen A, Vahtera J, Virtanen M, Westerholm PJ, Westerlund H, Zins M, Steptoe A, Theorell T (October 2012). "Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data". Lancet. 380 (9852): 1491–97. doi:10.1016/S0140-6736(12)60994-5. PMC 3486012  . PMID 22981903.
Jump up ^ Hackshaw, Allan; Morris, Joan K; Boniface, Sadie; Tang, Jin-Ling; Milenković, Dušan (24 January 2018). "Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports". BMJ: j5855. doi:10.1136/bmj.j5855.
Jump up ^ Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT (July 2012). "Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy". Lancet. 380 (9838): 219–29. doi:10.1016/S0140-6736(12)61031-9. PMC 3645500  . PMID 22818936.
Jump up ^ "Agent Orange: Diseases Associated with Agent Orange Exposure". Department of Veterans Affairs Office of Public Health and Environmental Hazards. 25 March 2010. Archived from the original on 9 May 2010. Retrieved 4 May 2010.
Jump up ^ Esdaile, JM; Abrahamowicz, M; Grodzicky, T; Li, Y; Panaritis, C; du Berger, R; Côte, R; Grover, SA; Fortin, PR; Clarke, AE; Senécal, JL (October 2001). "Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus". Arthritis and Rheumatism. 44 (10): 2331–7. doi:10.1002/1529-0131(200110)44:10<2331::aid-art395>3.0.co;2-i. PMID 11665973.
Jump up ^ Kerola, AM; Kauppi, MJ; Kerola, T; Nieminen, TV (October 2012). "How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?". Annals of the Rheumatic Diseases. 71 (10): 1606–15. doi:10.1136/annrheumdis-2012-201334. PMID 22736093.
^ Jump up to: a b Wang HX, Leineweber C, Kirkeeide R, Svane B, Schenck-Gustafsson K, Theorell T, Orth-Gomér K (March 2007). "Psychosocial stress and atherosclerosis: family and work stress accelerate progression of coronary disease in women. The Stockholm Female Coronary Angiography Study". J. Intern. Med. 261 (3): 245–54. doi:10.1111/j.1365-2796.2006.01759.x. PMID 17305647.
Jump up ^ Andreassi, John L. (2000). Psychophysiology: human behavior and physiological response. Mahwah, NJ: L. Erlbaum. p. 287.
Jump up ^ McCann S.J.H. (November 2001). "The precocity-longevity hypothesis: earlier peaks in career achievement predict shorter lives". Pers Soc Psychol Bull. 27 (11): 1429–39. doi:10.1177/01461672012711004. Archived from the original on 3 September 2015.
Rhodewalt; Smith (1991). "Current issues in Type A behaviour, coronary proneness, and coronary heart disease". In Snyder, C.R.; Forsyth, D.R. Handbook of social and clinical psychology: the health perspective. New York: Pergamon. pp. 197–220. ISBN 0080361285.
Jump up ^ Underwood and Cross, James (2009). General and Systematic Pathology. London, UK: Churchhill livingstone. p. 279.
Jump up ^ Kannel, WB; Vasan, RS (Jul 2009). "Triglycerides as vascular risk factors: new epidemiologic insights". Current Opinion in Cardiology. 24 (4): 345–50. doi:10.1097/HCO.0b013e32832c1284. PMC 3012388  . PMID 19424059.
Jump up ^ Danesh J, Collins R, Peto R (2000). "Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies". Circulation. 102 (10): 1082–85. doi:10.1161/01.CIR.102.10.1082. PMID 10973834. Archived from the original on 5 July 2011.
Jump up ^ Smolders B, Lemmens R, Thijs V (2007). "Lipoprotein (a) and stroke: a meta-analysis of observational studies". Stroke. 38 (6): 1959–66. doi:10.1161/STROKEAHA.106.480657. PMID 17478739.
Jump up ^ Schreiner PJ, Morrisett JD, Sharrett AR, Patsch W, Tyroler HA, Wu K, Heiss G (1993). "Lipoprotein(a) as a risk factor for preclinical atherosclerosis" (PDF). Arterioscler. Thromb. 13 (6): 826–33. doi:10.1161/01.ATV.13.6.826. PMID 8499402. Archived (PDF) from the original on 17 May 2011.
^ Jump up to: a b "Scientific Report of the 2015 Dietary Guidelines Advisory COmmittee" (PDF). health.gov. Feb 2015. p. Part D, Chapter 1, Page 17 (642). Archived (PDF) from the original on 3 May 2016.
Jump up ^ McPherson, R; Tybjaerg-Hansen, A (19 February 2016). "Genetics of Coronary Artery Disease". Circulation Research. 118 (4): 564–78. doi:10.1161/circresaha.115.306566. PMID 26892958. Archived from the original on 20 August 2017.
Jump up ^ Khera, AV; Kathiresan, S (June 2017). "Genetics of coronary artery disease: discovery, biology and clinical translation". Nature Reviews Genetics. 18 (6): 331–344. doi:10.1038/nrg.2016.160. PMID 28286336.
Jump up ^ Mu, Fan; Rich-Edwards, Janet; Rimm, Eric B.; Spiegelman, Donna; Missmer, Stacey A. (29 March 2016). "Endometriosis and Risk of Coronary Heart Disease". Circulation: Cardiovascular Quality and Outcomes. pp. CIRCOUTCOMES.115.002224. doi:10.1161/CIRCOUTCOMES.115.002224. Retrieved 31 March 2016.
Jump up ^ Albus, C (October 2010). "Psychological and social factors in coronary heart disease". Annals of Medicine. 42 (7): 487–94. doi:10.3109/07853890.2010.515605. PMID 20839918.
Jump up ^ Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS (1998). "Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults". Am J Prev Med. 14 (4): 245–58. doi:10.1016/S0749-3797(98)00017-8. PMID 9635069.
Jump up ^ Grant PJ (2003). "The genetics of atherothrombotic disorders: a clinician's view". J Thromb Haemost (Review). 1 (7): 1381–90. doi:10.1046/j.1538-7836.2003.00276.x. PMID 12871271. Archived from the original on 10 November 2016.
Jump up ^ Padmanaban P, Toora BD. Hemoglobin: Emerging marker in stable coronary artery disease. Chron Young Sci [serial online] 2011 [cited 2011 July 24];2:109–10. Available from: http://www.cysonline.org/text.asp?2011/2/2/109/82971
Jump up ^ Fajar, J. K. (2016). The β fibrinogen gene G-455A polymorphism in Asian subjects with coronary heart disease: A meta analysis. Egyptian Journal of Medical Human Genetics.
Jump up ^ Ambrose, John; Singh, Manmeet (2015). "Pathophysiology of coronary artery disease leading to acute coronary syndromes". F1000Prime Reports. 7. doi:10.12703/P7-08. ISSN 2051-7599. PMC 4311268  . PMID 25705391.
Jump up ^ Aziz, S (2005). "Chronic total occlusions—a stiff challenge requiring a major breakthrough: is there light at the end of the tunnel?". Heart. 91 (suppl_3): iii42–iii48. doi:10.1136/hrt.2004.058495. ISSN 1355-6037.
Jump up ^ Lanza GA (February 2007). "Cardiac syndrome X: a critical overview and future perspectives". Heart. 93 (2): 159–66. doi:10.1136/hrt.2005.067330. PMC 1861371  . PMID 16399854.
Jump up ^ Jones E, Eteiba W, Merz NB (August 2012). "Cardiac syndrome X and microvascular coronary dysfunction". Trends in Cardiovascular Medicine. 22 (6): 161–68. doi:10.1016/j.tcm.2012.07.014. PMC 3490207  . PMID 23026403.
Jump up ^ Kaski JC (February 2004). "Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X)". Circulation. 109 (5): 568–72. doi:10.1161/01.CIR.0000116601.58103.62. PMID 14769677.
^ Jump up to: a b American Society of Echocardiography. "Five Things Physicians and Patients Should Question". Choosing Wisely: an initiative of the ABIM Foundation. American Society of Echocardiography. Archived from the original on 26 February 2013. Retrieved 27 February 2013. , citing
Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, Picard MH, Polk DM, Ragosta M, Ward RP, Weiner RB (2011). "ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography". Journal of the American College of Cardiology. 57 (9): 1126–66. doi:10.1016/j.jacc.2010.11.002. PMID 21349406. CS1 maint: Multiple names: authors list (link)
Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV (2003). "ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article". Journal of the American College of Cardiology. 41 (1): 159–68. doi:10.1016/S0735-1097(02)02848-6. PMID 12570960. CS1 maint: Multiple names: authors list (link)
Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK, Smith SC, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Nishimura R, Ohman EM, Page RL, Stevenson WG, Tarkington LG, Yancy CW (2010). "2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults". Journal of the American College of Cardiology. 56 (25): e50–103. doi:10.1016/j.jacc.2010.09.001. PMID 21144964.
Jump up ^ American College of Cardiology (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American College of Cardiology, archived from the original on 17 December 2013, retrieved 10 February 2014
Jump up ^ "Coronary Angiography". National Heart, Blood, and Lung Institute. Retrieved 10 December 2017.
^ Jump up to: a b Li, Y. Robert (2015), "Chapter 13: Overview of ischemic heart disease, stable angina, and drug therapy", Cardiovascular Diseases: From Molecular Pharmacology to Evidence-Based Therapeutics (1st ed.), John Wiley and Sons, ISBN 978-0-470-91537-0.
Jump up ^ Fihn, SD; et al. (2014), "2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons", Circulation, 30 (19): 1749–1767, doi:10.1161/CIR.0000000000000095, PMID 25070666.
Jump up ^ European Society of Cardiology (2014), Stable Coronary Artery Disease (Management of): ESC Clinical Practice Guidelines, retrieved 2017-09-14.
Jump up ^ McGill, Henry C.; McMahan, C. Alex; Gidding, Samuel S. (2008-03-04). "Preventing Heart Disease in the 21st Century". Circulation. 117 (9): 1216–1227. doi:10.1161/CIRCULATIONAHA.107.717033. ISSN 0009-7322. PMID 18316498.
Jump up ^ McNeal, Catherine J.; Dajani, Tala; Wilson, Don; Cassidy-Bushrow, Andrea E.; Dickerson, Justin B.; Ory, Marcia (2010-01-01). "Hypercholesterolemia in youth: opportunities and obstacles to prevent premature atherosclerotic cardiovascular disease". Current Atherosclerosis Reports. 12 (1): 20–28. doi:10.1007/s11883-009-0072-0. ISSN 1534-6242. PMID 20425267.
Jump up ^ Naci, H.; Ioannidis, J. P. A. (1 October 2013). "Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study". BMJ. 347 (oct01 1): f5577–f5577. doi:10.1136/bmj.f5577.
Jump up ^ Kyu, Hmwe H; Bachman, Victoria F; Alexander, Lily T; Mumford, John Everett; Afshin, Ashkan; Estep, Kara; Veerman, J Lennert; Delwiche, Kristen; Iannarone, Marissa L; Moyer, Madeline L; Cercy, Kelly; Vos, Theo; Murray, Christopher J L; Forouzanfar, Mohammad H (9 August 2016). "Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013". BMJ. 354: i3857. doi:10.1136/bmj.i3857. PMC 4979358  . PMID 27510511.
Jump up ^ Ebrahim, Shah; Taylor, Fiona; Ward, Kirsten; Beswick, Andrew; Burke, Margaret; Davey Smith, George (19 January 2011). Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd. doi:10.1002/14651858.cd001561.pub3. Archived from the original on 28 July 2017.
Jump up ^ "5. Population nutrient intake goals for preventing diet-related chronic diseases". WHO. Archived from the original on 29 December 2015. Retrieved 26 October 2015.
Jump up ^ Wang, X; Ouyang, Y; Liu, J; Zhu, M; Zhao, G; Bao, W; Hu, FB (29 July 2014). "Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies". BMJ (Clinical research ed.). 349: g4490. doi:10.1136/bmj.g4490. PMC 4115152  . PMID 25073782.
Jump up ^ Li, D (30 January 2014). "Effect of the vegetarian diet on non-communicable diseases". Journal of the science of food and agriculture. 94 (2): 169–73. doi:10.1002/jsfa.6362. PMID 23965907.
Jump up ^ Huang, T; Yang, B; Zheng, J; Li, G; Wahlqvist, ML; Li, D (2012). "Cardiovascular disease mortality and cancer incidence in vegetarians: a meta-analysis and systematic review". Annals of Nutrition and Metabolism. 60 (4): 233–40. doi:10.1159/000337301. PMID 22677895.
Jump up ^ Ginter, E (2008). "Vegetarian diets, chronic diseases and longevity". Bratislavske lekarske listy. 109 (10): 463–6. PMID 19166134.
Jump up ^ Walker C, Reamy BV (April 2009). "Diets for cardiovascular disease prevention: what is the evidence?". Am Fam Physician. 79 (7): 571–8. PMID 19378874.
Jump up ^ Threapleton DE, Greenwood DC, Evans CE, Cleghorn CL, Nykjaer C, Woodhead C, Cade JE, Gale CP, Burley VJ (2013). "Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis". BMJ. 347: f6879. doi:10.1136/bmj.f6879. PMC 3898422  . PMID 24355537.
Jump up ^ Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB (2005). "Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction". J Nutr. 135 (3): 562–66. PMID 15735094.
Jump up ^ Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC (April 2006). "Trans fatty acids and cardiovascular disease". N. Engl. J. Med. 354 (15): 1601–13. doi:10.1056/NEJMra054035. PMID 16611951.
Jump up ^ Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS (September 2012). "Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events A Systematic Review and Meta-analysis". JAMA. 308 (10): 1024–1033. doi:10.1001/2012.jama.11374. PMID 22968891.
Jump up ^ Kwak SM, Myung SK, Lee YJ, Seo HG (2012-04-09). "Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized, Double-blind, Placebo-Controlled Trials". Archives of Internal Medicine. 172 (9): 686–94. doi:10.1001/archinternmed.2012.262. PMID 22493407.
Jump up ^ Erkkilä AT, Booth SL (2008). "Vitamin K intake and atherosclerosis". Curr. Opin. Lipidol. 19 (1): 39–42. doi:10.1097/MOL.0b013e3282f1c57f. PMID 18196985.
Jump up ^ Linden W, Stossel C, Maurice J (April 1996). "Psychosocial interventions for patients with coronary artery disease: a meta-analysis". Arch. Intern. Med. 156 (7): 745–52. doi:10.1001/archinte.1996.00440070065008. PMID 8615707.
Jump up ^ Swardfager W, Herrmann N, Cornish S, Mazereeuw G, Marzolini S, Sham L, Lanctôt KL (2012). "Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis". Am Heart J. 163 (4): 666–76. doi:10.1016/j.ahj.2011.12.017. PMID 22520533. Retrieved 26 October 2015.
Jump up ^ How to Increase Your HDL Cholesterol Levels Archived 14 July 2006 at the Wayback Machine.; accessed 26 October 2015.
Jump up ^ "Coronary Heart Disease (CHD)". Penguin Dictionary of Biology. 2004.
Jump up ^ "Behavioral counseling in primary care to promote physical activity: recommendation and rationale". Ann. Intern. Med. 137 (3): 205–07. 2002. doi:10.7326/0003-4819-137-3-200208060-00014. PMID 12160370.
Jump up ^ Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, Fletcher GF, Gordon NF, Pate RR, Rodriguez BL, Yancey AK, Wenger NK (2003). "Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)". Circulation. 107 (24): 3109–16. doi:10.1161/01.CIR.0000075572.40158.77. PMID 12821592.
Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Major Recommendations Archived 22 October 2007 at the Wayback Machine.; accessed 26 October 2015.
Jump up ^ Jameson JN, Kasper DL, Harrison TR, Braunwald E, Fauci AS, Hauser SL, Longo DL (2005). Harrison's principles of internal medicine (16th ed.). New York: McGraw-Hill Medical Publishing Division. ISBN 0-07-140235-7. OCLC 54501403. Archived from the original on 19 February 2014. Retrieved 26 October 2015.
Jump up ^ Gutierrez J, Ramirez G, Rundek T, Sacco RL (25 June 2012). "Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis". Archives of Internal Medicine. 172 (12): 909–19. doi:10.1001/archinternmed.2012.2145. PMID 22732744.
Jump up ^ "Nitroglycerin Sublingual: MedlinePlus Drug Information". medlineplus.gov. Archived from the original on 6 January 2017.
^ Jump up to: a b Ohman, EM (March 2016). "CLINICAL PRACTICE. Chronic Stable Angina". New England Journal of Medicine. 374 (12): 1167–76. doi:10.1056/NEJMcp1502240. PMID 27007960.
Jump up ^ Grove, EL; Würtz, M; Thomas, MR; Kristensen, SD (2015). "Antiplatelet therapy in acute coronary syndromes". Expert Opinion on Pharmacotherapy (Review). 16 (14): 2133–47. doi:10.1517/14656566.2015.1079619. PMID 26293612.
^ Jump up to: a b Rosendorff, C; Lackland, DT; Allison, M; Aronow, WS; Black, HR; Blumenthal, RS; Cannon, CP; de Lemos, JA; Elliott, WJ; Findeiss, L; Gersh, BJ; Gore, JM; Levy, D; Long, JB; O'Connor, CM; O'Gara, PT; Ogedegbe, O; Oparil, S; White, WB (31 March 2015). "Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension". Circulation. 131: e435–70. doi:10.1161/cir.0000000000000207. PMID 25829340.
Jump up ^ Guirguis-Blake, JM; Evans, CV; Senger, CA; O'Connor, EA; Whitlock, EP (21 June 2016). "Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force.". Annals of Internal Medicine (Systematic Review and Meta-Analysis). 164 (12): 804–13. doi:10.7326/M15-2113. PMID 27064410.
Jump up ^ U.S. Preventive Services Task Force (15 January 2002). "Aspirin for the primary prevention of cardiovascular events: recommendation and rationale". Ann Intern Med. 136 (2): 157–60. doi:10.7326/0003-4819-136-2-200201150-00015. PMID 11790071. Archived from the original on 6 October 2009. Retrieved 26 October 2015.
Jump up ^ Squizzato, Alessandro; Keller, Tymen; Romualdi, Erica; Middeldorp, Saskia (2011-01-19). "Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease". The Cochrane Database of Systematic Reviews (1): CD005158. doi:10.1002/14651858.CD005158.pub3. ISSN 1469-493X. PMID 21249668.
Jump up ^ "FDA Drug Safety Communication: FDA review finds long-term treatment with blood-thinning medicine Plavix (clopidogrel) does not change risk of death". FDA. 11-06-2015. Archived from the original on 4 February 2016. Retrieved 25 January 2016. Check date values in: |date= (help)
Jump up ^ Elmariah, Sammy; Mauri, Laura; Doros, Gheorghe; Galper, Benjamin Z; O'Neill, Kelly E; Steg, Philippe Gabriel; Kereiakes, Dean J; Yeh, Robert W (November 2014). "Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis". The Lancet. 385: 792–798. doi:10.1016/S0140-6736(14)62052-3. PMC 4386690  . PMID 25467565.
Jump up ^ Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC (October 2002). "ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)". Circulation. 106 (14): 1893–1900. doi:10.1161/01.CIR.0000037106.76139.53. PMID 12356647. Archived from the original on 3 July 2011. Retrieved 26 October 2015.
Jump up ^ Stergiopoulos K, Boden WE, Hartigan P, Möbius-Winkler S, Hambrecht R, Hueb W, Hardison RM, Abbott JD, Brown DL (2014). "Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials". JAMA Intern Med. 174 (2): 232–40. doi:10.1001/jamainternmed.2013.12855. PMID 24296791.
Jump up ^ Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C (2014). "Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era". JAMA Intern Med. 174 (2): 223–30. doi:10.1001/jamainternmed.2013.12844. PMID 24296767.
Jump up ^ Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C (1 February 2014). "Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era". JAMA Internal Medicine. 174 (2): 223–30. doi:10.1001/jamainternmed.2013.12844. PMID 24296767.
Jump up ^ Zhao, Dong Fang (28 February 2017). "Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta: A Network Meta-Analysis". Journal of the American College of Cardiology. 69 (8): 924–936. doi:10.1016/j.jacc.2016.11.071. Archived from the original on 28 February 2017.
Jump up ^ "WHO Disease and injury country estimates". World Health Organization. 2009. Archived from the original on 11 November 2009. Retrieved 11 November 2009.
^ Jump up to: a b Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. (15 December 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-0. hdl:10536/DRO/DU:30050819. PMID 23245604.
^ Jump up to: a b Finegold JA, Asaria P, Francis DP (4 December 2012). "Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations". International Journal of Cardiology. 168 (2): 934–45. doi:10.1016/j.ijcard.2012.10.046. PMC 3819990  . PMID 23218570.
Jump up ^ Indian Heart Association Why South Asians Facts Archived 18 May 2015 at the Wayback Machine., 29 April 2015; accessed 26 October 2015.
Jump up ^ "Kochanek KD, Xu JQ, Murphy SL, Miniño AM, Kung HC" (PDF). Archived (PDF) from the original on 16 January 2013. Retrieved 25 March 2013.
Jump up ^ Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y (February 2007). "Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee". Circulation. 115 (5): e69–171. doi:10.1161/CIRCULATIONAHA.106.179918. PMID 17194875. Archived from the original on 8 June 2011. Retrieved 26 October 2015.
Jump up ^ American Heart Association:Heart Disease and Stroke Statistics-2007 Update. AHA, Dallas, Texas, 2007 Archived 1 July 2007 at the Wayback Machine.
Jump up ^ "Other Names for Coronary Heart Disease". 29 September 2014. Archived from the original on 13 February 2015. Retrieved 23 February 2015.
Jump up ^ ICP, bmj.com; accessed 25 October 2015.
Jump up ^ Infarct Combat Project website Archived 12 August 2015 at the Wayback Machine.; accessed 26 October 2015.
Jump up ^ O'Connor, Anahad, "How the Sugar Industry Shifted Blame to Fat" Archived 28 February 2017 at the Wayback Machine., The New York Times, September 12, 2016. Retrieved 2016-09-12.
Jump up ^ Kearns, CE; Schmidt, LA; Glantz, SA (12 September 2016). "Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents". JAMA Internal Medicine. 176: 1680–1685. doi:10.1001/jamainternmed.2016.5394. PMC 5099084  . PMID 27617709.
Jump up ^ Nestle, Marion (12 September 2016). "Invited Commentary:Food Industry Funding of Nutrition Research: The Relevance of History for Current Debates". JAMA Internal Medicine. 176: 1685. doi:10.1001/jamainternmed.2016.5400. PMID 27618496.
Jump up ^ Deena Shanker (12 September 2016). "How Big Sugar Enlisted Harvard Scientists to Influence How We Eat—in 1965". Bloomberg News. Archived from the original on 2 February 2017.
Jump up ^ Ifill, Gwen (13 September 2016). "How the sugar industry paid experts to downplay health risks". PBS NewsHour. Archived from the original on 20 August 2017.
Jump up ^ Farrall M, Green FR, Peden JF, Olsson PG, Clarke R, Hellenius ML, Rust S, Lagercrantz J, Franzosi MG, Schulte H, Carey A, Olsson G, Assmann G, Tognoni G, Collins R, Hamsten A, Watkins H (2006). "Genome-Wide Mapping of Susceptibility to Coronary Artery Disease Identifies a Novel Replicated Locus on Chromosome 17". PLoS Genetics. 2 (5): e72. doi:10.1371/journal.pgen.0020072. PMC 1463045  . PMID 16710446.
Jump up ^ Roberts, R; Stewart, AF (January 2012). "9p21 and the genetic revolution for coronary artery disease". Clinical Chemistry. 58 (1): 104–12. doi:10.1373/clinchem.2011.172759. PMID 22015375.
Jump up ^ Dandona, S; Stewart, AF; Roberts, R (March 2010). "Genomics in coronary artery disease: past, present and future". The Canadian journal of cardiology. 26 Suppl A: 56A–59A. doi:10.1016/s0828-282x(10)71064-3. PMID 20386763.
Jump up ^ Saikku P, Leinonen M, Tenkanen L, Linnanmäki E, Ekman MR, Manninen V, Mänttäri M, Frick MH, Huttunen JK (1992). "Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study". Annals of Internal Medicine. 116 (4): 273–78. doi:10.7326/0003-4819-116-4-273. PMID 1733381.
Jump up ^ Grayston, JT; Belland, RJ; Byrne, GI; Kuo, CC; Schachter, J; Stamm, WE; Zhong, G (February 2015). "Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested". Pathogens and disease. 73 (1): 1–9. doi:10.1093/femspd/ftu015. PMC 4492408  . PMID 25854002.
Jump up ^ Andrews R, Berger JS, Brown DL (2005). "Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials". JAMA. 293 (21): 2641–47. doi:10.1001/jama.293.21.2641. PMID 15928286.
Jump up ^ Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, Laham RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK (September 2000). "Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary". Circulation. 102 (11): E73–86. doi:10.1161/01.CIR.102.11.e73. PMID 10982554. Retrieved 26 October 2015.
Jump up ^ Stegmann TJ (December 1998). "FGF-1: a human growth factor in the induction of neoangiogenesis". Expert Opin Investig Drugs. 7 (12): 2011–15. doi:10.1517/13543784.7.12.2011. PMID 15991943.
Jump up ^ Wagoner L.E.; Merrill W.; Jacobs J.; Conway G.; Boehmer J.; Thomas K.; Stegmann T.J. (2007). "Angiogenesis Protein Therapy With Human Fibroblast Growth Factor (FGF-1) Results of a Phase I Open Label, Dose Escalation Study in Subjects With CAD Not Eligible For PCI Or CABG". Circulation. 116: 443. Archived from the original on 15 October 2015.
Jump up ^ Loria V, Dato I, Graziani F, Biasucci LM (2008). "Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes". Mediators Inflamm. 2008: 135625. doi:10.1155/2008/135625. PMC 2276594  . PMID 18382609.
Jump up ^ Esselstyn, C. B. (2001-01-01). "Resolving the Coronary Artery Disease Epidemic Through Plant-Based Nutrition". Preventive Cardiology. 4 (4): 171–177. doi:10.1111/j.1520-037x.2001.00538.x. ISSN 1751-7141. PMID 11832674.
External links[edit]
Classification
V · T · D
ICD-10: I20-I25
ICD-9-CM: 410-414, 429.2
MeSH: D003324
External resources
MedlinePlus: 007115
eMedicine: radio/192
Patient UK: Coronary artery disease

Risk Assessment of having a heart attack or dying of coronary artery disease, from the American Heart Association.
[show]
v
t
e
Cardiovascular disease (heart) (I00–I52, 390–429)
Ischaemic
Coronary disease
Coronary artery disease (CAD)
Coronary artery aneurysm
Spontaneous coronary artery dissection (SCAD)
Coronary thrombosis
Coronary vasospasm
Myocardial bridge
Active ischemia
Angina pectoris
Prinzmetal's angina
Stable angina
Acute coronary syndrome
Myocardial infarction
Unstable angina
Sequelae
hours
Hibernating myocardium
Myocardial stunning
days
Myocardial rupture
weeks
Aneurysm of heart / Ventricular aneurysm
Dressler syndrome
Layers
Pericardium
Pericarditis
Acute
Chronic / Constrictive
Pericardial effusion
Cardiac tamponade
Hemopericardium
Myocardium
Myocarditis
Chagas disease
Cardiomyopathy
Dilated
Alcoholic
Hypertrophic
Restrictive
Loeffler endocarditis
Cardiac amyloidosis
Endocardial fibroelastosis
Arrhythmogenic right ventricular dysplasia
Endocardium /
valves
Endocarditis
infective endocarditis
Subacute bacterial endocarditis
non-infective endocarditis
Libman–Sacks endocarditis
Nonbacterial thrombotic endocarditis
Valves
mitral
regurgitation
prolapse
stenosis
aortic
stenosis
insufficiency
tricuspid
stenosis
insufficiency
pulmonary
stenosis
insufficiency
Conduction /
arrhythmia
Bradycardia
Sinus bradycardia
Sick sinus syndrome
Heart block: Sinoatrial
AV
1°
2°
3°
Intraventricular
Bundle branch block
Right
Left
Left anterior fascicle
Left posterior fascicle
Bifascicular
Trifascicular
Adams–Stokes syndrome
Tachycardia
(paroxysmal and sinus)
Supraventricular
Atrial
Multifocal
Junctional
AV nodal reentrant
Junctional ectopic
Ventricular
Accelerated idioventricular rhythm
Catecholaminergic polymorphic
Torsades de pointes
Premature contraction
Atrial
Junctional
Ventricular
Pre-excitation syndrome
Lown–Ganong–Levine
Wolff–Parkinson–White
Flutter / fibrillation
Atrial flutter
Ventricular flutter
Atrial fibrillation
Familial
Ventricular fibrillation
Pacemaker
Ectopic pacemaker / Ectopic beat
Multifocal atrial tachycardia
Pacemaker syndrome
Parasystole
Wandering pacemaker
Long QT syndrome
Andersen–Tawil
Jervell and Lange-Nielsen
Romano–Ward
Cardiac arrest
Sudden cardiac death
Asystole
Pulseless electrical activity
Sinoatrial arrest
Other / ungrouped
hexaxial reference system
Right axis deviation
Left axis deviation
QT
Short QT syndrome
T
T wave alternans
ST
Osborn wave
ST elevation
ST depression
Strain pattern
Cardiomegaly
Ventricular hypertrophy
Left
Right / Cor pulmonale
Atrial enlargement
Left
Right
Other
Cardiac fibrosis
Heart failure
Diastolic heart failure
Cardiac asthma
Rheumatic fever
Retrieved from "https://en.wikipedia.org/w/index.php?title=Coronary_artery_disease&oldid=833534273"
Categories:
Aging-associated diseases
Heart diseases
Ischemic heart diseases
Hidden categories:
CS1 maint: Explicit use of et al.
CS1 maint: Multiple names: authors list
Webarchive template wayback links
CS1 errors: dates
Use dmy dates from September 2013
Infobox medical condition (new)
All articles with unsourced statements
Articles with unsourced statements from October 2015
Articles needing additional references from October 2015
All articles needing additional references
All Wikipedia articles needing clarification
Wikipedia articles needing clarification from December 2017
Articles with unsourced statements from March 2013
All articles with failed verification
Articles with failed verification from October 2016
Wikipedia articles in need of updating from December 2017
All Wikipedia articles in need of updating
RTT
RTTEM
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Article
Talk
Variants
Views
Read
Edit
View history
More
Search
Navigation
Main page
Contents
Featured content
Current events
Random article
Donate to Wikipedia
Wikipedia store
Interaction
Help
About Wikipedia
Community portal
Recent changes
Contact page
Tools
What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Wikidata item
Cite this page
Print/export
Create a book
Download as PDF
Printable version
In other projects
Wikimedia Commons
Languages
العربية
Bân-lâm-gú
Беларуская
Български
Català
Čeština
Dansk
Deutsch
Ελληνικά
Español
فارسی
Français
Gaeilge
Galego
한국어
Հայերեն
Bahasa Indonesia
Íslenska
Italiano
עברית
Latviešu
Lietuvių
Magyar
Македонски
Bahasa Melayu
မြန်မာဘာသာ
Nederlands
日本語
Norsk
ଓଡ଼ିଆ
Polski
Português
Română
Runa Simi
Русский
Simple English
Slovenčina
Slovenščina
Српски / srpski
Srpskohrvatski / српскохрватски
Suomi
Svenska
தமிழ்
తెలుగు
ไทย
Türkçe
Українська
ئۇيغۇرچە / Uyghurche
Tiếng Việt
中文
41 more
Edit links
This page was last edited on 1 April 2018, at 04:38.
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view
Enable previews

values: mw-page-base noprint

values: mw-head-base noprint

values: firstHeading firstHeading en

values: siteSub noprint

values: jump-to-nav mw-jump

value: p

attrs: colspan style

value: sup

value: img

attrs: href class

values:
/wiki/Diagnostic_method
mw-redirect
Diagnostic method

values: Coronary computed tomographic angiography

values:
/wiki/Medical_use_of_nitroglycerin
mw-redirect
Medical use of nitroglycerin

values:
/wiki/Stable_angina
mw-redirect
Stable angina

values:
/wiki/Sudden_cardiac_death
mw-redirect
Sudden cardiac death

values:
/wiki/Stress_(psychological)
mw-redirect
Stress (psychological)

values:
/wiki/Most_common_causes_of_death
mw-redirect
Most common causes of death

values:
/wiki/Type_A_personality
mw-redirect
Type A personality

values:
/wiki/Genome-wide_association_studies
mw-redirect
Genome-wide association studies

attrs: alt src width height class srcset data-file-width data-file-height

values:
/wiki/Coronary_artery
mw-redirect
Coronary artery

values:
/wiki/Masson%27s_trichrome
mw-redirect
Masson's trichrome

values:
/wiki/Ventricular_arrhythmia
mw-redirect
Ventricular arrhythmia

values:
/wiki/Atheromatous_plaque
mw-redirect
Atheromatous plaque

values:
/wiki/Cardiac_syndrome_X
mw-redirect
Cardiac syndrome X

values:
/wiki/Angina_pectoris
mw-redirect
Angina pectoris

values:
/wiki/Microvascular_dysfunction
mw-redirect
Microvascular dysfunction

values:
/wiki/Stress_echocardiography
mw-redirect
Stress echocardiography

values:
/wiki/Coronary_angiography
mw-redirect
Coronary angiography

values:
/wiki/Chest_X-ray
mw-redirect
Chest X-ray

values: This claim needs references to reliable sources. (October 2015)

values:
noprint Inline-Template Template-Fact
white-space:nowrap;

values:
/wiki/Medical_ultrasonography
mw-redirect
Medical ultrasonography

values: Help:Introduction to referencing with Wiki Markup/1

values: plainlinks metadata ambox ambox-content ambox-Unreferenced

values:
/wiki/Cardiac_arrhythmia
mw-redirect
Cardiac arrhythmia

values:
/wiki/Framingham_Score
mw-redirect
Framingham Score

values:
/wiki/Waist_circumference
mw-redirect
Waist circumference

values:
/wiki/Blood_sugar
mw-redirect
Blood sugar

values:
/wiki/Diet_and_heart_disease
mw-redirect
Diet and heart disease

values:
/wiki/High_fiber_diet
mw-redirect
High fiber diet

values:
/wiki/Weight_control
mw-redirect
Weight control

values:
/wiki/Coronary_artery_bypass_grafting
mw-redirect
Coronary artery bypass grafting

values: This information is too vague. (December 2017)

values: This claim needs references to reliable sources. (March 2013)

values:
/wiki/Coronary_artery_bypass_graft
mw-redirect
Coronary artery bypass graft

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffff20; color:black; font-size:100%; text-align:center;

values: -webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffe820; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffd820; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffc020; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffa020; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff9a20; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #f08015; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #e06815; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #d85010; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #d02010; color:black; font-size:100%; text-align:center;

values: refbegin columns references-column-count references-column-count-3

values: -moz-column-count: 3; -webkit-column-count: 3; column-count: 3;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #b3b3b3; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffff65; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #fff200; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffdc00; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffc600; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffb000; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff9a00; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff8400; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff6e00; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff5800; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff4200; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff2c00; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #cb0000; color:black; font-size:100%; text-align:center;

values: refbegin columns references-column-count references-column-count-2

values: -moz-column-count: 2; -webkit-column-count: 2; column-count: 2;

values:
/wiki/Ischemic_heart_disease
mw-redirect
Ischemic heart disease

values: Edit section: Industry influence on research

values: Doesn't say which archives and IIRC it was a researcher's archives, not the Assn's (October 2016)

values:
/wiki/New_England_Journal_of_Medicine
mw-redirect
New England Journal of Medicine

values:
/wiki/Healthy_eating
mw-redirect
Healthy eating

values:
/wiki/Chromosome_17_(human)
mw-redirect
Chromosome 17 (human)

values:
/wiki/Progenitor_cells
mw-redirect
Progenitor cells

values: The date of the event predicted near this tag has passed. (December 2017)

values: Wikipedia:Manual of Style/Dates and numbers

values:
/wiki/PubMed_Identifier
mw-redirect
PubMed Identifier

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15173041

values:
nofollow
external text
//doi.org/10.1016%2Fj.tcm.2014.10.005

attrs: alt src title width height srcset data-file-width data-file-height

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25453985

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27733282

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27733281

values:
nofollow
external text
//doi.org/10.1038%2Fnrcardio.2014.26

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24663092

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25530442

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24274053

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24522859

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24844736

values:
nofollow
external text
//doi.org/10.1001%2Fjama.2013.281718

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24240936

values:
nofollow
external text
//doi.org/10.12998%2Fwjcc.v3.i2.163

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25685763

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24573352

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24573351

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21993341

values:
nofollow
external text
//doi.org/10.4065%2Fmcp.2009.0560

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20194155

values:
nofollow
external text
//doi.org/10.4330%2Fwjc.v8.i1.1

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26839654

values: Category:CS1 maint: Explicit use of et al.

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22981903

values:
nofollow
external text
//doi.org/10.1136%2Fbmj.j5855

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22818936

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11665973

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22736093

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17305647

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19424059

values:
nofollow
external text
//doi.org/10.1161%2F01.CIR.102.10.1082

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10973834

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17478739

values:
nofollow
external text
//doi.org/10.1161%2F01.ATV.13.6.826

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8499402

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26892958

values:
nofollow
external text
//doi.org/10.1038%2Fnrg.2016.160

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/28286336

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20839918

values:
/wiki/Am_J_Prev_Med
mw-redirect
Am J Prev Med

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9635069

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12871271

values:
nofollow
external text
//doi.org/10.12703%2FP7-08

values:
nofollow
external text
//www.worldcat.org/issn/2051-7599

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25705391

values:
nofollow
external text
//doi.org/10.1136%2Fhrt.2004.058495

values:
nofollow
external text
//www.worldcat.org/issn/1355-6037

values:
nofollow
external text
//doi.org/10.1136%2Fhrt.2005.067330

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16399854

values:
nofollow
external text
//doi.org/10.1016%2Fj.tcm.2012.07.014

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23026403

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/14769677

values:
/wiki/ABIM_Foundation
mw-redirect
ABIM Foundation

values:
nofollow
external text
//doi.org/10.1016%2Fj.jacc.2010.11.002

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21349406

values: Category:CS1 maint: Multiple names: authors list

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12570960

values:
nofollow
external text
//doi.org/10.1016%2Fj.jacc.2010.09.001

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21144964

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25070666

values:
nofollow
external text
//www.worldcat.org/issn/0009-7322

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18316498

values:
nofollow
external text
//www.worldcat.org/issn/1534-6242

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20425267

values:
nofollow
external text
//doi.org/10.1136%2Fbmj.f5577

values:
nofollow
external text
//doi.org/10.1136%2Fbmj.i3857

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27510511

values:
nofollow
external text
//doi.org/10.1136%2Fbmj.g4490

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25073782

values:
nofollow
external text
//doi.org/10.1002%2Fjsfa.6362

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23965907

values:
nofollow
external text
//doi.org/10.1159%2F000337301

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22677895

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19166134

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19378874

values:
nofollow
external text
//doi.org/10.1136%2Fbmj.f6879

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24355537

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15735094

values:
nofollow
external text
//doi.org/10.1056%2FNEJMra054035

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16611951

values:
nofollow
external text
//doi.org/10.1001%2F2012.jama.11374

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22968891

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22493407

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18196985

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8615707

values:
nofollow
external text
//doi.org/10.1016%2Fj.ahj.2011.12.017

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22520533

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12160370

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12821592

values:
nofollow
external text
//www.worldcat.org/oclc/54501403

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22732744

values:
nofollow
external text
//doi.org/10.1056%2FNEJMcp1502240

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27007960

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26293612

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25829340

values:
nofollow
external text
//doi.org/10.7326%2FM15-2113

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27064410

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11790071

values:
nofollow
external text
//www.worldcat.org/issn/1469-493X

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21249668

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25467565

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12356647

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24296791

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24296767

values:
nofollow
external text
//doi.org/10.1016%2Fj.jacc.2016.11.071

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23245604

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23218570

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17194875

values:
nofollow
external text
http://www.infarctcombat.org

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27617709

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27618496

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16710446

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22015375

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20386763

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/1733381

values:
nofollow
external text
//doi.org/10.1093%2Ffemspd%2Fftu015

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25854002

values:
nofollow
external text
//doi.org/10.1001%2Fjama.293.21.2641

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15928286

values:
nofollow
external text
//doi.org/10.1161%2F01.CIR.102.11.e73

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10982554

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15991943

values:
nofollow
external text
//doi.org/10.1155%2F2008%2F135625

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18382609

values:
nofollow
external text
//www.worldcat.org/issn/1751-7141

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11832674

values: International Statistical Classification of Diseases and Related Health Problems

values: width:22em;width:100%; margin:0 0 0.5em 0;

values: ICD-10 Chapter IX: Diseases of the circulatory system

values: List of ICD-9 codes 390–459: diseases of the circulatory system

values:
/wiki/Prinzmetal%27s_angina
mw-redirect
Prinzmetal's angina

values:
/wiki/Angina_pectoris#Stable_angina
mw-redirect
Angina pectoris

values: Arrhythmogenic right ventricular dysplasia

values: Electrical conduction system of the heart

values: Catecholaminergic polymorphic ventricular tachycardia

values:
/wiki/Osborn_wave
mw-redirect
Osborn wave

values:
/wiki/Diastolic_heart_failure
mw-redirect
Diastolic heart failure

values: nowraplinks hlist collapsible collapsed navbox-inner

values: Category:Webarchive template wayback links

values: Category:Use dmy dates from September 2013

values: Category:Infobox medical condition (new)

values: Category:All articles with unsourced statements

values: Category:Articles with unsourced statements from October 2015

values: Category:Articles needing additional references from October 2015

values: Category:All articles needing additional references

values: Category:All Wikipedia articles needing clarification

values: Category:Wikipedia articles needing clarification from December 2017

values: Category:Articles with unsourced statements from March 2013

values: Category:All articles with failed verification

values: Category:Articles with failed verification from October 2016

values: Category:Wikipedia articles in need of updating from December 2017

values: Category:All Wikipedia articles in need of updating

values: Discussion about edits from this IP address [ctrl-alt-n]

values: A list of edits made from this IP address [ctrl-alt-y]

values: You are encouraged to create an account and log in; however, it is not mandatory

values: You're encouraged to log in; however, it's not mandatory. [ctrl-alt-o]

values:
/wiki/Coronary_artery_disease
View the content page [ctrl-alt-c]
c

values: Discussion about the content page [ctrl-alt-t]

values: p-namespaces navigation vectorTabs p-namespaces-label

values:
p-variants
navigation
vectorMenu emptyPortlet
p-variants-label

values: Recent changes in pages linked from this page [ctrl-alt-k]

values:
/wiki/Wikipedia:File_Upload_Wizard
Upload files [ctrl-alt-u]
u

values: A list of all special pages [ctrl-alt-q]

values: Permanent link to this revision of the page

values: Link to connected data repository item [ctrl-alt-g]

values: Printable version of this page [ctrl-alt-p]

values: portal navigation p-wikibase-otherprojects p-wikibase-otherprojects-label

values: مرض القلب التاجي – Arabic

values: Koan-chōng tōng-me̍h sim-chōng-pēⁿ – Chinese (Min Nan)

values:
interlanguage-link interwiki-zh-min-nan
display: none;

values: Ішэмічная хвароба сэрца – Belarusian

values:
interlanguage-link interwiki-be
display: none;

values: Исхемична болест на сърцето – Bulgarian

values:
interlanguage-link interwiki-bg
display: none;

values: Malaltia de les artèries coronàries – Catalan

values:
interlanguage-link interwiki-ca
display: none;

values:
interlanguage-link interwiki-cs
display: none;

values:
interlanguage-link interwiki-da
display: none;

values:
interlanguage-link interwiki-de
display: none;

values: Στεφανιαία καρδιακή νόσος – Greek

values:
interlanguage-link interwiki-el
display: none;

values: Enfermedad de las arterias coronarias – Spanish

values: بیماری سرخرگ کرونری – Persian

values:
interlanguage-link interwiki-fa
display: none;

values:
interlanguage-link interwiki-ga
display: none;

values:
interlanguage-link interwiki-gl
display: none;

values: 관상동맥질환 – Korean

values:
interlanguage-link interwiki-ko
display: none;

values: Կարդիոսկլերոզ – Armenian

values:
interlanguage-link interwiki-hy
display: none;

values:
interlanguage-link interwiki-is
display: none;

values:
interlanguage-link interwiki-it
display: none;

values: מחלת לב כלילית – Hebrew

values:
interlanguage-link interwiki-he
display: none;

values:
interlanguage-link interwiki-lv
display: none;

values:
interlanguage-link interwiki-lt
display: none;

values:
interlanguage-link interwiki-hu
display: none;

values: Коронарна артериска болест – Macedonian

values:
interlanguage-link interwiki-mk
display: none;

values: နှလုံးသွေးကြောကျဉ်းရောဂါ – Burmese

values:
interlanguage-link interwiki-my
display: none;

values:
interlanguage-link interwiki-nl
display: none;

values:
interlanguage-link interwiki-ja
display: none;

values:
interlanguage-link interwiki-no
display: none;

values: କରୋନାରୀ ଧମନୀ ରୋଗ – Odia

values:
interlanguage-link interwiki-or
display: none;

values: interlanguage-link interwiki-pl badge-Q17437796 badge-featuredarticle

values: Doença arterial coronariana – Portuguese

values:
interlanguage-link interwiki-ro
display: none;

values:
interlanguage-link interwiki-qu
display: none;

values: Коронарная недостаточность – Russian

values: Coronary artery disease – Simple English

values:
interlanguage-link interwiki-simple
display: none;

values:
interlanguage-link interwiki-sk
display: none;

values: Koronarna arterijska bolezen – Slovenian

values:
interlanguage-link interwiki-sl
display: none;

values: Коронарна артеријска болест – Serbian

values:
interlanguage-link interwiki-sr
display: none;

values:
interlanguage-link interwiki-sh
display: none;

values:
interlanguage-link interwiki-fi
display: none;

values:
interlanguage-link interwiki-sv
display: none;

values: குருதி ஊட்டக்குறை இதய நோய் – Tamil

values:
interlanguage-link interwiki-ta
display: none;

values: కొరోనరీ ఆర్టరీ వ్యాధి – Telugu

values:
interlanguage-link interwiki-te
display: none;

values: โรคหลอดเลือดเลี้ยงหัวใจ – Thai

values:
interlanguage-link interwiki-th
display: none;

values:
interlanguage-link interwiki-tr
display: none;

values: Ішемічна хвороба серця – Ukrainian

values:
interlanguage-link interwiki-uk
display: none;

values: تاجىسىمان يۇرەك قان تومۇر كېسىلى – Uyghur

values:
interlanguage-link interwiki-ug
display: none;

values:
interlanguage-link interwiki-vi
display: none;

values: 冠狀動脈疾病 – Chinese

values: All languages (initial selection from common choices by you and others)

values: /static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x

values: /static/images/poweredby_mediawiki_132x47.png 1.5x, /static/images/poweredby_mediawiki_176x62.png 2x

values:
suggestions
display: none; font-size: 13px;

values: mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Coronary_artery_disease rootpage-Coronary_artery_disease skin-vector action-view